Basic information
Biomarker: ER
Histology type: endometrioid endometrial carcinoma
Cohort characteristics
Country: Japan
Region: Saga
Followed up time :
Subgroup 1 name : PR-positive
Subgroup 1 number: 50
Subgroup 2 name: ER-positive
Subgroup 2 number: 42
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
92 | EEC | 92 |
Sample information
Conclusion: PR/ER immunohistochemistry was significantly related to survival and PR immunohistochemistry appeared to be the most reliable means for predicting survival in endometrioid adenocarcinoma of the endometrium, independent of other clinicopathological parameters.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : negative
Disease information
Statictics: Mean ;Range
Cohort age: 60.3;31-86
Related information
Funtion Uniprot: Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism. Induces the expression of PERM1 in the skeletal muscle.
UniProt ID: P11474
UniProt Link: https://www.uniprot.org/uniprotkb/P11474/entry
Biological function from UniProt: #Transcription #Transcription regulation
Molecular function from UniProt:
Subcellular UniProt: #Cytoplasm #Nucleus
Alternative name from UniProt:
Recommended name: Steroid hormone receptor ERR1
Gene name from HGNC: ESRRA (ERR1, ERRa, ERRalpha, ESRL1, NR3B1)
HPA class: Nuclear receptors Transcription factors
AlphaFold DB: P11474
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P11474
Induction: Induced by PGC1alpha in a number of specific cell types including heart, kidney and muscle.
HPA link: https://www.proteinatlas.org/ENSG00000173153-ESRRA
Tissue specificity RNA from HPA: Tissue enhanced (skeletal muscle)
Tissue expression from HPA: General cytoplasmic expression.
Single cell type specificity Cell type enhanced (Hepatocytes, Proximal enterocytes, Distal enterocytes)
Immune cell specificity: Low immune cell specificity
Subcellular summary HPA Located in Nucleoplasm, Nucleoli fibrillar center, Microtubules, Cytokinetic bridge (Single cell variability, CCD Protein)
Cancer prognostic summary HPA Prognostic marker in renal cancer (favorable)
Pathology link: https://www.proteinatlas.org/ENSG00000173153-ESRRA/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000173153-ESRRA/pathology/endometrial+cancer
OMIM: 601998
OMIM link2: https://www.omim.org/entry/601998
HGNC ID: HGNC:3471
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3471